Alice Di Rocco | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi	LEUKEMIA & LYMPHOMA	2021
Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study	LEUKEMIA	2021
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study	IN VIVO	2020
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma	HEMATOLOGICAL ONCOLOGY	2020
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study	LEUKEMIA	2020
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation	HEMATOLOGICAL ONCOLOGY	2020
Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma	LEUKEMIA & LYMPHOMA	2020
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy	LEUKEMIA & LYMPHOMA	2020
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma	AMERICAN JOURNAL OF HEMATOLOGY	2019
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma. a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI)	LEUKEMIA & LYMPHOMA	2019
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma	BRITISH JOURNAL OF HAEMATOLOGY	2019
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study	HAEMATOLOGICA	2019
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network	EUROPEAN JOURNAL OF CANCER CARE	2019
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study	HAEMATOLOGICA	2019
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial	THE LANCET	2019
Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue	HEMASPHERE	2019
MYC Rearranged Aggressive B-Cell Lymphomas	HEMASPHERE	2019
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Patients: A Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy	BLOOD	2019
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma	BLOOD	2018
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death	BRITISH JOURNAL OF HAEMATOLOGY	2018

Progetti di Ricerca

The impact of different treatment strategies on minimal residual disease (MRD) in young and elderly Mantle cell lymphoma (MCL) patients.
Non invasive monitoring of aggressive lymphomas by next generation sequencing/droplet digital PCR on circulating tumor-DNA (ct-DNA)